🇺🇸 FDA
Patent

US 11230549

Quinolino-pyrrolidin-2-one derivative and application thereof

granted A61KA61K31/4745A61K31/7048

Quick answer

US patent 11230549 (Quinolino-pyrrolidin-2-one derivative and application thereof) held by Medshine Discovery Inc. expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/4745, A61K31/7048, A61K45/06, A61P